Free Dermatology CME

  • FREE

    Healio Free Dermatology CME

    Find out what over 50,000 of your colleagues already know. Earn credits faster and easier with Healio CME.

    See full details chevron_right
    • Cost: Free
  • FREE

    ScientiaCME Dermatology CME

    Target Audience: Physicians focusing on Allergy, Dermatology

    See full details chevron_right
    • Cost: Free
    • Credit hours: 3
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Expiration of CME credit: Two years after release
  • FREE

    ScientiaCME Allergy – Urticaria and Psoriasis

    Target Audience: Physicians focusing on Allergy or Dermatology

    See full details chevron_right
    • Cost: Free
    • Credit hours: 2
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Expiration of CME credit: Two years after release
  • FREE

    Systemic lupus erythematosus: therapeutic updates and optimizing treatment

    Activity Description / Statement of Need:

    Systemic lupus erythematosus (SLE) is an autoimmune disease with heterogeneous etiologies and clinical phenotypes, all with varying degrees of severity. Although the precise mechanism of SLE-related autoimmunity is still uncertain, strong evidence implicates a combination of genetic and environmental factors in the disease pathology. For most of the medical community, the primary challenges of SLE management stem from the disease heterogeneity, which leads to difficulty in diagnosing, treating, and monitoring.

    Evidence suggests that there are a number of gaps in the treatment of lupus stemming from a suboptimal patient-provider relationship. Suggested remedies include a: patient-centered approach to care, improvement of disease awareness, focus on taking adequate time to provide disease and treatment information as well as treatment adherence, and sensitivity to patient concerns.

    Target Audience:

    Rheumatologists and primary care physicians and other specialists who care for patients with SLE (e.g., dermatologists, nephrologists, OBGYNs); physician assistants, nurse practitioners, and pharmacists who practice in rheumatology; and any other HCPs with an interest in or who clinically encounter patients with SLE.

    By the end of the session the participant will be able to:

    • Describe the pathophysiology of systemic lupus erythematosus (SLE), with a focus on the factors affecting disease progression, remission, and therapeutic mechanisms
    • Recall identification of SLE disease activity, flares, and treatment goals, both short- and long-term
    • Describe the influence of disease activity and corticosteroid use on organ damage in SLE
    • Evaluate available and emerging therapeutic options for SLE, individualizing treatment regimens based on patient and disease characteristics
    • Discuss the role and importance of patient-provider communication in charting a course of optimal treatment
    See full details chevron_right
    • Credit hours: .75
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: 12/17/2020
    • Expiration of CME credit: 12/17/2022
  • FREE

    Updates in psoriasis management: Contemporary practice and novel therapies

    Activity Description / Statement of Need:

    In this online, self-learning activity:

    Psoriasis, characterized by chronic inflammation of the skin and hyperproliferation and abnormal differentiation of the stratified epidermis, is one of the most common autoimmune diseases in the US. With a clinical presentation of red, scaly plaques on the skin that range in severity from minor, localized lesions to complete body coverage, it is also associated with inflammation of the joints and enthesial attachments and has potential of articular destruction—a complication known as psoriatic arthritis that affects up to 30% of those with the disease. Aside from its direct effects on the skin, it is also reduces quality of life associated with cardiac and psychiatric comorbidities. Over half of patients with psoriasis are unsatisfied with their disease management, and half of patients with mild disease are untreated while the same is true for a fifth of patients with severe disease.

    This activity has been designed to bring HCPs’ knowledge of current and emerging screening and treatment strategies for psoriasis up to date and to improve their competence and performance in treating it. This program has also been designed to review treatment strategies and raise awareness of gaps in care of patients with psoriasis and review strategies to promote adherence.

    Target Audience:

    HCPs specializing in: Dermatologists and primary care physicians; physician assistants, nurse practitioners, and pharmacists who practice in dermatology; and any other healthcare professionals with an interest in or who clinically encounter patients with psoriasis.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1.25
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: 10/05/2021
    • Expiration of CME credit: 10/05/2023
  • FREE

    Identification and management moderate-to-severe psoriatic arthritis: stopping the disease in its tracks and meeting unmet needs

    Activity Description / Statement of Need:

    Psoriatic arthritis (PsA) is a chronic, progressive disease that, untreated, may be associated with permanent joint damage, disability, impaired quality of life, and cardiovascular disease. Globally, it affects 0.1-1% of people, it is a common comorbidity of patients with psoriasis, affecting up to a quarter of those with moderate-to-severe disease. affecting them in a quarter percent of the U.S. population. PsA is an immune-mediated disease characterized by inflammation of the skin and nails disease or a family history of psoriasis in association with pluralistic musculoskeletal disease that may involve entheses, the spine, and peripheral joints. Unlike the clinical manifestations of inflammatory, pathophysiological processes of psoriasis, a failure to intervene early in PsA with treatment often results in damage that is irreversible. In all, patients with PsA incur about four times the direct medical costs as compared to the average medical patient.

    This accredited educational activity identifies the critical components of the management process and offer solutions to close gaps in diagnosis and care, with the ultimate goals being the improvement of psoriatic arthritis management, treatment adherence, and health and cost outcomes. 

    Target Audience:

    The following HCPs: rheumatologists, dermatologists, and primary care physicians; physician assistants, nurse practitioners, and pharmacists who practice in rheumatology and immunology; and any other HCPs with an interest in or who clinically encounter patients with PsA.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: 02/23/2022
    • Expiration of CME credit: 02/23/2023